PAART (Predictors of Adherence to Antiretroviral Therapy) is an open, prospective clinical observational cohort, established in October 2013. Patients are recruited from hospital outpatient clinics, sexual health clinics and high HIV-caseload general practices.
The project involves the roll-out of targeted interventions at multiple hospital sites in Queensland and New South Wales, with a focus on Surgical Antibiotic Prophylaxis (SAP) and its social and behavioural underpinnings.
Until recently, the experience and outcomes of health care have been conceptualised and measured from the perspective of clinicians or researchers. While important, these measures may obscure or miss issues that are of central relevance to the experience of the patient.
The Flux study is a longitudinal cohort study investigating drug use among gay and bisexual men. The study aims to identify factors associated with current drug use, future uptake, or cessation of drug use, as well as changes in patterns of drug use, and the consequences of drug use.
Enhancing Treatment of Hepatitis C in Opioid Substitution Settings
This study aims to evaluate the impact of an intervention integrating non-invasive liver disease screening on HCV assessment and treatment in drug and alcohol clinics, and to develop a translational framework for subsequ
The COUNT study is designed to provide robust estimates of the prevalence of HIV and undiagnosed infection among gay and bisexual men and identify factors associated with undiagnosed infection. An earlier version of the study was conducted in 2013-14.
CSRH has been commissioned by ACT Health to undertake research to examine stigma and discrimination experienced among priority populations affected by sexually transmissible infections (STI) and blood borne viruses (BBV) in the ACT.